Gangnam Severance Hospital has recently confirmed that immediate intraoperative radiation therapy (IORT) after surgical resection in pancreatic cancer patients could increase the survival rate by increasing immune response with changes in the lymphocyte population.The research team, led by Professor
CHA Biotech’s patented technology to culture and freeze natural killer (NK) cells has been featured in the Journal of Experimental and Clinical Cancer Research, an international journal providing a quality forum with all oncology works.In collaboration with a research team led by Professor An Hee-ju
Researchers at Seoul National University Bundang Hospital (SNUBH) have developed the first program to enhance the social skills of people with autism spectrum disorders (ASD) who have had difficulties in social life after reaching adulthood.The Program for the Education and Enrichment of Relational
Researchers at a state agency have found the key to unlocking ways to pinpoint RNA-binding sites (RBSs) or provide direct evidence for RNA-binding, which is essential for regulating life phenomena.The publication marks another significant finding from a research team led by Kim V. Narry, director of
MDimune has agreed with China’s NeoCura Bio-Medical Technology (NeoCura), a company specializing in RNA therapeutics, to conduct collaborative studies of cell-derived vesicles (CDV)-based mRNA therapeutic cancer vaccines.Under the accord, the two companies will jointly seek opportunities of developi
DeepBio has obtained approval from the ethics committee of the University of Utah to conduct a real-world study to validate the performance of its AI-based prostate cancer diagnosis software with ARUP Laboratories.At the University of Utah ARUP Laboratories, the company intends to assess the impact
The mRNA vaccines against the Covid-19 pandemic have also shed light on the related technology as a next-generation vaccine for seasonal influenza. However, Korean companies remain cautious because of uncertain marketability, industry executives said Friday.Global pharmaceuticals, including Moderna,
Gangnam Severance Hospital said a new, calorie-restricted Korean-style Mediterranean diet (KMD) developed by its researchers helped reduce cardiovascular risk by improving chronic inflammation, insulin resistance, and fatty liver.The research team, led by Professor Lee Ji-won of the Department of Fa
CancerRop, which specializes in genetic analysis and molecular diagnostics, said Thursday that it signed a 3 billion won ($2.55-million) contract with COREE Company to collaborate in immune cell profiling to establish data for developing vaccines.Under the accord, CancerRop will also cooperate with
The Korea Disease Control and Prevention Agency (KDCA) reported Wednesday that the nation’s Covid-19 vaccination rate stood at 66.7 percent and rose to 77.7 percent when only people over 18 years of age were counted.The total number of Koreans who have received the second shot surpassed over 34 mill
A well-known dermatologist on Wednesday stressed the need for consumers to put the tolerance of botulinum toxin (BTX) products ahead of all else in getting injections.At an online conference held by the Korean Society for Cosmetic Dermatology, Vice-Chairman Seo Koo-il emphasized the importance of un
A bioscience research team at the Korea Advanced Institute of Science and Technology (KAIST) has developed a next-generation chimeric antigen receptor T (CAR-T) cell therapy that overcomes immune checkpoint signals.CAR-T cell therapy is a treatment that increases anticancer function by introducing t
Lunit, a company focusing on artificial intelligence software, said it has signed an agreement with Medpacto to develop AI-based biomarkers.The two companies will work on collaborative projects analyzing cancer tissues using AI platforms, exchanging developers' technology and knowledge, and driving
In the 1990s, soon after Professor Suh Kyung-suk became a physician, Korea’s liver cancer surgery techniques were not very advanced, lagging far behind Japan’s.About three decades later, a set of superlative modifiers -- the most, the first, and the leading -- follow Professor Suh and his liver tran
Daewoong Pharmaceuticals and inno.N, the two Korean frontrunners in potassium-competitive acid blocker (P-CAB) drugs for gastroesophageal reflux disease (GERD), are fiercely competing to carve out a larger share in the global market.inno.N won the title of the first Korean company to develop a new d
DeepBio said that Stanford University’s research team has released study results on DeepDx-Prostate, the company’s deep learning-based software that diagnoses prostate cancer, at the annual meeting of the American Urological Association (AUA).The researchers at Stanford University School of Medicine
Hugel, a Korean aesthetics and therapeutics developer, said the European Medicines Agency (EMA) has completed an on-site inspection of its plant in Chuncheon, Gangwon Province, manufacturing its botulinum toxin (BTX) brand, Letybo.The plant produces more than five million BTX vials a year with the l
A research team at Korea Atomic Energy Research Institute (KAERI) has developed a nanomedicine that can be used as a carrier delivering vaccine and anticancer drugs without accumulating in the liver.The state-run institute said Wednesday that the iron oxide nanomedicine, developed by KAERI’s Advance
CureVac said it has decided to stop developing its first-generation mRNA Covid-19 vaccine candidate, CVnCoV, due to disappointing efficacy in phase 3 clinical trials and focus on a more promising second-generation vaccine with GSK.The company expected to get approval for CVnCoV in the second quarter
Cellid, a developer of virus vector Covid-19 vaccine candidate, AdCLD-CoV19-1, said it has joined the COVAX Marketplace that allocates raw materials for vaccines.The innovative market coordinated by COVAX provides suppliers with a platform to allocate or reallocate unused materials for vaccines, mob